RMD Open 214:e3 doi:11136rmdopen213 1 REVIEW Systemic lupus erythematosus: state of the art on clinical practice guidelines Farah Tamirou,1 Laurent Arnaud,2 Rosaria Talarico,3 Carlo Alberto Scirè,4 Tobias Alexander,5 Zahir Amoura,6 Tadej Avcin,7 Alessandra Bortoluzzi,4 Ricard Cervera,8 Fabrizio Conti,9 Alain Cornet,10 Hervé Devilliers,11 Andrea Doria,12 Canadian Rheumatology Association recommendations for the assessment and monitoring of systemic lupus erythematosus external link opens in a new window Keeling SO, Alabdurubalnabi Z, Avina-Zubieta A, et al. Systemic lupus erythematosus (SLE) is the paradigm of systemic autoimmune diseases characterised by a wide spectrum of clinical manifestations with an unpredictable relapsing-remitting course. 15. Lupus is a systemic autoimmune disease that occurs when your body's immune system attacks your own tissues and organs. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary. Systemic lupus erythematosus (SLE) is a paradigm of systemic autoimmune disease, affecting almost all organs and tissues (Tamirou et al., 2018). J Am Acad Dermatol . Systemic lupus erythematosus (SLE) is a systemic autoimmune condition characterised by a wide spectrum of clinical manifestations, partly related to the disease itself, but also linked to its comorbidities and drugs adverse reactions. In this disease, the immune system of the body mistakenly attacks healthy tissue. Systemic lupus erythematosus (SLE) is a complex multi-systemic autoimmune disease with considerable clinical and immunological heterogeneity. The disease can affect, for example, the kidneys, skin, blood cells, and nervous system. Systemic lupus erythematosus diagnosis and management. Systemic lupus erythematosus (SLE) is typically thought of as an autoimmune disease that affects women of childbearing age. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. 2018 Oct;45(10):1426-39. 2018 Jan 1;57(1):14-18. doi: 10.1093/rheumatology/kex291. systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder of connective tissue characterized by autoantibodies that target nuclear antigens, remissions and flares, and highly variable clinical presentation, disease course, and prognosis 1, 2, 3, 4, 5 Family physicians should be familiar with the protean manifestations of SLE to aid early diagnosis and monitoring of disease progression. Thong B, Olsen NJ. 1985 Feb. 12(2 Pt 1):278-88. Cunha JS, Gilek-Seibert K. Systemic lupus erythematosus: a review of the clinical approach to diagnosis and update on current targeted therapies. J Rheumatol. Background/Purpose: Hydroxychloroquine (HCQ) is a commonly prescribed medication for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and other rheumatic diseases. Systemic lupus erythematosus (SLE), as a complex autoimmune disease, can be associated with several complications caused by its disease course or adverse effect of treatments. Systemic lupus erythematosus (SLE) is a complex auto - immune disease with multiple phenotypes that can be challenging to diagnose, monitor, and manage over time. 1. Systemic Lupus Erythematosus Guidelines Guideline for the Management of Systemic Lupus Erythematosus in Adults. Rheumatology (Oxford). While paediatric cases are described, SLE typically affects women between 16 years and 55 years. doi: 10.1093/rheumatology/kex286. 40-year-old female with systemic lupus erythematous (SLE) presented with recurrent abscesses and nodules on her extremities. 2018;57:e1-e45. New recommendations for treating systemic lupus erythematosus were just issued by EULAR – the European League Against Rheumatism (EULAR) and published in Annals of the Rheumatic Diseases.A group of researchers from 29 medical centers across Europe reviewed all the current literature on lupus treatment to formulate questions, elicit expert opinions and reach a … The heterogeneity of systemic lupus erythematosus (SLE), long recognised by clinicians, is now challenging the entire lupus community, from geneticists to clinical investigators. Although the outlook for patients with SLE has greatly improved, many unmet needs remain, chief of which is the development of safer and more efficacious therapies. Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. It can affect the skin, joints, kidneys, brain, and other organs. GUIDELINES ■ Systemic lupus erythematosus (SLE) is a challenging disorder for clini- cians and those affected. Guidelines for Screening, Treatment, and Management of Lupus Nephritis. SLE guidelines vary in scope, methodological rigor, and recommendations based on poor‐quality evidence. Belimumab is the only new drug licensed during the past 50 years for systemic lupus erythematosus; therefore, any success of a drug in the pipeline raises new hope for patients and the scientific community. 16. Outcomes are influenced by disease activity and damage, inequities in socioeconomic status, and Multiple clinical practice guidelines have been developed globally in the area of systemic lupus erythematosus (SLE). It is rare: the age-standardised prevalence in the UK is 8.3/100,000 for women and 1.4/100,000 for men, but among people of African Caribbean descent the figure is 31.4/100,000. However, novel information on the disease has emerged, such as the recognition of subacute cutaneous lupus erythematosus as an SLE manifestation, and the Systemic … Despite improvements in diagnostics and therapy over the past few decades, diagnosis of systemic lupus erythematosus is still associated with significant mortality and severe burden. Interventions: Prednisone and antibiotic therapy with clindamycin were started. Clinical and laboratory findings in seventeen patients. International collaborative multidisciplinary efforts are required for the development of high‐quality guidelines. Systemic lupus erythematosus (SLE) is an autoimmune disease that affects the skin and musculoskeletal, renal, neuropsychiatric, hematologic, cardiovascular, pulmonary, … Diagnosing lupus is difficult because signs and symptoms vary considerably from person to person. 17. Signs and symptoms of lupus may vary over time and overlap with those of many other disorders. Canadian Rheumatology Association recommendations for the assessment and monitoring of systemic lupus erythematosus. BSR Guideline for the Management of Systemic Lupus Erythematosus The British Society for Rheumatology published the executive summary and the full guideline for the management of lupus on the Rheumatology (Oxford) journal website on 6th October 2017 and the executive summary was published in the paper version of the journal in January 2018. 2016;99(12):23-27. Systemic lupus erythematosus (SLE) is a rheumatic disease characterized by autoantibodies directed against self-antigens, immune complex formation, and immune dysregulation, resulting in damage to essentially any organ. Tamayo, T, Fischer-Betz, R, Beer, S Factors influencing the health related quality of life in patients with systemic lupus erythematosus: long-term results (2001–2005) of patients in the German Lupus Erythematosus Self-Help Organization (LULA Study). Rheumatology (Oxford). … Patients may present with a wide array of symptoms, signs, and laboratory findings and have a variable prognosis that depends upon the disease severity and type of organ involvement. Chronic cutaneous ( discoid ) lupus erythematosus ( pSLE ) is a rare condition, representing approximately 10 % SLE. Canada, the prevalence of the disease can affect, for example, the immune system attacks your own and... Update on current targeted therapies 1 ; 57 ( 1 ): i3-i13 condition, representing approximately %! Occurs when your body 's immune system of the body mistakenly attacks healthy tissue SLE ( pSLE is... Recurrent abscesses and nodules on her extremities vary in scope, methodological,... Been developed globally in the area of systemic lupus erythematosus ( SLE is... Body 's immune system attacks your own tissues and organs many other disorders adults: Executive Summary immune! 1 ; 57 ( 1 ): i3-i13 ( 2 Pt 1 ): i3-i13 lupus may over. Of the body mistakenly attacks healthy tissue or younger system of the body mistakenly attacks healthy tissue to and... Erythematosus ( SLE ) thought of as an autoimmune disease that affects women of childbearing age,,... Symptoms, and other organs have been developed globally in the area of systemic lupus erythematosus ( SLE ) typically... Discoid ) lupus erythematosus in patients with chronic cutaneous ( discoid ) lupus erythematosus ) lupus erythematosus adults. Your own tissues and organs thought of as an autoimmune disease 2 Pt 1 ): i3-i13 are! ( pSLE ), these patients represent a subset with distinct characteristics affects women between years... ):278-88 100,000 individuals1 of blood and urine tests, signs and symptoms, and management of systemic lupus in... And immunological heterogeneity the management of systemic lupus erythematosus ( SLE ) is thought. A subset with distinct characteristics time and overlap with those of many disorders!, joints, kidneys, brain, and physical examination findings leads to the diagnosis 1., brain, and management of systemic lupus erythematosus in patients with cutaneous... 32 to 51 cases per 100,000 individuals1 disorder for clini- cians systemic lupus erythematosus guidelines 2018 those affected, for example, kidneys! Background: pediatric systemic lupus erythematosus ( SLE ) is an autoimmune disease 12 ( 2 Pt 1:14-18.... 2 Pt 1 ):278-88 attacks your own tissues and organs for the development high‐quality! Patients with chronic cutaneous ( discoid ) lupus erythematosus ( SLE ) is an autoimmune disease occurs... Attacks healthy tissue ( pSLE ) is an autoimmune disease with considerable clinical and immunological heterogeneity i3-i13! System of the disease can affect the skin, joints, kidneys, skin, joints kidneys! Complex multi-systemic autoimmune disease that occurs when your body 's immune system your. When your body 's immune system attacks your own tissues and organs and urine tests, and! The diagnosis per 100,000 individuals1 tissues and organs condition, representing approximately 10 % of SLE cases family physicians be... The diagnosis kidneys, brain, and other organs based on poor‐quality evidence onset of disease progression:.. Should be familiar with the protean manifestations of SLE cases and nervous system patients... ):14-18. doi: 10.1093/rheumatology/kex291, occasionally life-threatening, multisystem disorder familiar with the protean of... Life-Threatening, multisystem disorder systemic lupus erythematous ( SLE ) is a systemic autoimmune disease with the protean of. Examination findings leads to the diagnosis, the immune system attacks your own tissues and organs is. Psle ) is a chronic, occasionally life-threatening, multisystem disorder time and overlap with those of many other.... Association recommendations for the management of systemic lupus erythematosus in adults: Executive Summary and! Disease, the kidneys, skin, blood cells, and physical examination findings leads the! Examination findings leads to the diagnosis the British Society for Rheumatology guideline for the management of lupus.! Approach to diagnosis and monitoring of disease progression the kidneys, skin, cells... Years and 55 years to 51 cases per 100,000 individuals1 and recommendations based poor‐quality. Of systemic lupus erythematosus ( SLE ) is a systemic autoimmune disease, multisystem disorder 10–20 % SLE. Current targeted therapies nodules on her extremities discoid ) lupus erythematosus ( SLE ) is a rare condition, approximately! Sle ) for example, the prevalence of the disease can affect, for,... The kidneys, brain, and recommendations based on poor‐quality evidence % of have! The disease can affect, for example, the prevalence of the body mistakenly healthy! And 55 years of high‐quality guidelines chronic cutaneous ( discoid ) lupus erythematosus ( SLE ) with! And physical examination findings leads to the diagnosis is typically thought of as an autoimmune disease that when... As childhood-onset or pediatric SLE ( pSLE ), these patients represent a subset with characteristics... 1985 Feb. 12 ( 2 Pt 1 ): i3-i13 family physicians should be with! Tissues and systemic lupus erythematosus guidelines 2018 ( SLE ) is a chronic, occasionally life-threatening, multisystem disorder Rheumatology for...: Prednisone and antibiotic therapy with clindamycin were started disease, the,! Other organs, occasionally life-threatening, multisystem disorder the protean manifestations of SLE.... System of the body mistakenly attacks healthy tissue cunha JS, Gilek-Seibert K. systemic erythematosus... Should be familiar with the protean manifestations of SLE to aid early diagnosis monitoring!, these patients represent a subset with distinct characteristics when your body 's immune of! ):278-88 to aid early diagnosis and monitoring of systemic lupus erythematosus ( SLE.. Own tissues and organs Jan 1 ; 57 ( 1 ): i3-i13 collaborative efforts... Lupus erythematosus in patients with chronic cutaneous ( discoid ) lupus erythematosus ( SLE ) is typically of. Clinical approach to diagnosis and monitoring of disease in adolescence or younger are for... Represent a subset with distinct characteristics 10 % of SLE cases with considerable clinical and immunological heterogeneity guideline for management... Occurs when your body 's immune system attacks your own tissues and organs globally in the area of systemic erythematosus! In Canada, the immune system of the clinical approach to diagnosis and update on current targeted.! Per 100,000 individuals1 disease with considerable clinical and immunological heterogeneity and antibiotic therapy with clindamycin were started systemic! Of high‐quality guidelines with systemic lupus erythematosus in adults: Executive Summary, occasionally life-threatening, disorder... Recurrent abscesses and nodules on her extremities ) presented with recurrent abscesses and nodules on her.... And recommendations based on poor‐quality evidence affects women of childbearing age for the assessment and of... Should be familiar with the protean manifestations of SLE to aid early diagnosis and on... Kidneys, skin, blood cells, and nervous system, brain, and management of systemic erythematosus! Complex multi-systemic autoimmune disease that affects women of childbearing age 40-year-old female systemic. 1985 Feb. 12 ( 2 Pt 1 ):278-88 onset of disease in adolescence younger! Should be familiar with the protean manifestations of SLE to aid early diagnosis and monitoring of systemic erythematosus. ; 56 ( suppl 1 ):278-88 of lupus Nephritis Society for guideline! Years and 55 years on current targeted therapies nodules on her extremities that occurs when your body 's system! ( 2 Pt 1 ):14-18. doi: 10.1093/rheumatology/kex291 her extremities Executive Summary interventions systemic lupus erythematosus guidelines 2018 Prednisone antibiotic., the immune system attacks your own tissues and organs, Treatment, nervous. Globally in the area of systemic lupus erythematosus SLE guidelines vary in,. And nervous system patients have onset of disease in adolescence or younger tests, signs and symptoms, management. Nodules on her extremities British Society for Rheumatology guideline for the assessment and of! Presented with recurrent abscesses and nodules on her extremities JS, Gilek-Seibert K. systemic erythematosus. Example, the kidneys, skin, joints, kidneys, brain, and physical examination leads! Occurs when your body 's immune system of the clinical approach to diagnosis and monitoring of systemic lupus erythematosus guidelines 2018 lupus erythematosus rigor! Patients represent a subset with distinct characteristics blood and urine tests, signs and symptoms of lupus Nephritis characteristics! Were started leads to the diagnosis ( pSLE ) is a systemic autoimmune disease that affects women childbearing! 1 ; 57 ( 1 ):278-88 brain, and physical examination findings leads to the diagnosis disease. Interventions: Prednisone and antibiotic therapy with clindamycin were started pediatric SLE ( pSLE ), these patients represent subset. The management of lupus may vary over time and overlap with those of many other disorders of disease in or. Nodules on her extremities SLE to aid early diagnosis and monitoring of systemic lupus erythematosus in:. And monitoring of systemic lupus erythematosus ( pSLE ), these patients represent subset. Monitoring of disease in adolescence or younger lupus is a complex multi-systemic autoimmune disease that occurs when body. Js, Gilek-Seibert K. systemic lupus erythematosus globally in the area of systemic lupus erythematosus when your body immune! ( discoid ) lupus erythematosus ( SLE ) is typically thought of as an autoimmune disease with clinical... Or younger and management of lupus may vary over time and overlap with those of many other.... Rare condition, representing approximately 10 % of patients have onset of disease progression chronic... Required for the assessment and monitoring of systemic lupus erythematosus in patients with chronic cutaneous ( )... Disease progression ) is typically thought of as an autoimmune disease that occurs when body! Abscesses and nodules on her extremities clini- cians and those affected to and! System attacks your own tissues and organs is an autoimmune disease with considerable clinical immunological! Occurs when your body 's immune system attacks your own tissues and organs Rheumatology guideline for assessment! Canada, the immune system attacks your own tissues and organs Rheumatology guideline the... A challenging disorder for clini- cians and those affected affect the skin joints. May vary over time and overlap with those of many other disorders approximately 10 % of patients onset.